JPET Celsis microsomes equal better data

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ju, C.
Right arrow Articles by Uetrecht, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ju, C.
Right arrow Articles by Uetrecht, J. P.

Vol. 288, Issue 1, 51-56, January 1999

Detection of 2-Hydroxyiminostilbene in the Urine of Patients Taking Carbamazepine and Its Oxidation to a Reactive Iminoquinone Intermediate1

C. Ju and J. P. Uetrecht

Faculty of Pharmacy (C.J., J.P.U.) and Medicine (J.P.U.), University of Toronto, Toronto, Canada

Carbamazepine is one of the most widely used anticonvulsants in North America; however, its use is associated with a range of serious idiosyncratic adverse reactions. These reactions are thought to result from the formation of chemically reactive metabolites. Carbamazepine is extensively metabolized in the liver and one of the major metabolites is 2-hydroxycarbamazepine, which has previously been detected as a urinary metabolite excreted by rats and humans along with its further metabolized product, 2-hydroxyiminostilbene. In this study, we found that the urine of patients taking carbamazepine appeared to contain more of the glucuronide of 2-hydroxyiminostilbene than that of 2-hydroxycarbamazepine. We have also demonstrated that 2-hydroxyiminostilbene can be oxidized readily to an iminoquinone species by HOCl, H2O2 or even on exposure to air. The reactivity of this iminoquinone as an electrophile was studied. It was shown to react with sulfhydryl-containing nucleophiles, such as glutathione and N-acetylcysteine. We also found a metabolite with the same molecular weight as 4-methylthio-2-hydroxyiminostilbene, but not the corresponding carbamazepine derivative, in the urine of patients taking carbamazepine and this presumably reflects the formation of a glutathione conjugate of the reactive iminoquinone. This iminoquinone intermediate may play a role in carbamazepine-induced idiosyncratic reactions.

0022-3565/99/2881-0051$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 Drug Metab. Dispos.Home page
W. Lu and J. P. Uetrecht
Peroxidase-Mediated Bioactivation of Hydroxylated Metabolites of Carbamazepine and Phenytoin
Drug Metab. Dispos., August 1, 2008; 36(8): 1624 - 1636.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
R. E. Pearce, W. Lu, Y. Wang, J. P. Uetrecht, M. A. Correia, and J. S. Leeder
Pathways of Carbamazepine Bioactivation in Vitro. III. The Role of Human Cytochrome P450 Enzymes in the Formation of 2,3-Dihydroxycarbamazepine
Drug Metab. Dispos., August 1, 2008; 36(8): 1637 - 1649.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
R. E. Pearce, J. P. Uetrecht, and J. S. Leeder
PATHWAYS OF CARBAMAZEPINE BIOACTIVATION IN VITRO: II. THE ROLE OF HUMAN CYTOCHROME P450 ENZYMES IN THE FORMATION OF 2-HYDROXYIMINOSTILBENE
Drug Metab. Dispos., December 1, 2005; 33(12): 1819 - 1826.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
A. G. Staines, M. W. H. Coughtrie, and B. Burchell
N-Glucuronidation of Carbamazepine in Human Tissues Is Mediated by UGT2B7
J. Pharmacol. Exp. Ther., December 1, 2004; 311(3): 1131 - 1137.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
D. J. Naisbitt, M. Britschgi, G. Wong, J. Farrell, J. P. H. Depta, D. W. Chadwick, W. J. Pichler, M. Pirmohamed, and B. K. Park
Hypersensitivity Reactions to Carbamazepine: Characterization of the Specificity, Phenotype, and Cytokine Profile of Drug-Specific T Cell Clones
Mol. Pharmacol., March 1, 2003; 63(3): 732 - 741.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
R. E. Pearce, G. R. Vakkalagadda, and J. S. Leeder
Pathways of Carbamazepine Bioactivation in Vitro I. Characterization of Human Cytochromes P450 Responsible for the Formation of 2- and 3-Hydroxylated Metabolites
Drug Metab. Dispos., November 1, 2002; 30(11): 1170 - 1179.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
C. K. Svensson, E. W. Cowen, and A. A. Gaspari
Cutaneous Drug Reactions
Pharmacol. Rev., September 1, 2001; 53(3): 357 - 379.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
W. G. Lai, I. Gardner, N. Zahid, and J. P. Uetrecht
Bioactivation and Covalent Binding of Hydroxyfluperlapine in Human Neutrophils: Implications for Fluperlapine-Induced Agranulocytosis
Drug Metab. Dispos., March 1, 2000; 28(3): 255 - 263.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1999 by the American Society for Pharmacology and Experimental Therapeutics.